Filing Details
- Accession Number:
- 0001127602-19-006034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-14 17:01:35
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-14 17:01:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200845 | Jean-Luc Belingard | 531 South Spring Street Burlington NC 27215 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-12 | 3,700 | $64.42 | 36,779 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-12 | 3,700 | $146.06 | 33,079 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-02-12 | 1,038 | $0.00 | 34,117 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-12 | 104 | $146.59 | 34,013 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2019-02-12 | 3,700 | $0.00 | 3,700 | $64.42 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-12 | 1,038 | $0.00 | 1,038 | $0.00 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2019-02-12 | 1,227 | $0.00 | 1,227 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-06 | 2019-05-06 | No | 4 | M | Direct |
| 3,279 | No | 4 | M | Direct | ||
| 4,506 | No | 4 | A | Direct |
Footnotes
- Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- Stock withholding to satisfy tax withholding obligations.
- Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
- The Restricted Stock Units vested fully on February 12, 2019.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- Amount includes 105 Restricted Stock Units that were inadvertently omitted from the reporting person's original Form 4 filed on December 7, 2018, due to a clerical error.
- The Restricted Stock Units vest fully on February 12, 2020.
Billionaire Hedge Funds
